您的位置: 首页 > 农业专利 > 详情页

Methods for treating cancer by administering humanized pan-HER antibody compositions
专利权人:
发明人:
Johan Lantto,Kim Vilbour Andersen,Peter Sejer Andersen,Magnus Strandh,Klaus Koefoed,Lars Søgaard Nielsen,Mikkel Wandahl Pedersen,Helle Jacobsen,Michael Kragh,Ida Kjaer,Thomas Tuxen Poulsen
申请号:
US15350801
公开号:
US10058610B2
申请日:
2016.11.14
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention relates to humanized recombinant antibodies targeting the EGFR family receptors EGFR, HER2 and HER3, compositions comprising at least one humanized anti-EGFR antibody, at least one humanized anti-HER2 antibody and at least one humanized anti-HER3 antibody, and use of the antibody compositions for treatment of cancer. The invention also relates to the use of antibodies targeting multiple EGFR-family receptors to treat cancer (e.g., pancreatic cancer) and cancer that has acquired resistance to previous therapies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充